Polymyxins-Curcumin Combination Antimicrobial Therapy: Safety Implications and Efficacy for Infection Treatment
The emergence of antimicrobial resistance in Gram-negative bacteria poses a huge health challenge. The therapeutic use of polymyxins (i.e., colistin and polymyxin B) is commonplace due to high efficacy and limiting treatment options for multidrug-resistant Gram-negative bacterial infections. Nephrot...
Saved in:
Main Authors: | Chongshan Dai (Author), Yang Wang (Author), Gaurav Sharma (Author), Jianzhong Shen (Author), Tony Velkov (Author), Xilong Xiao (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Natural Product Curcumin as an Antibacterial Agent: Current Achievements and Problems
by: Chongshan Dai, et al.
Published: (2022) -
Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
by: Thien B. Tran, et al.
Published: (2018) -
Aflatoxin B1 Toxicity and Protective Effects of Curcumin: Molecular Mechanisms and Clinical Implications
by: Chongshan Dai, et al.
Published: (2022) -
Inhibition of Oxidative Stress and ALOX12 and NF-κB Pathways Contribute to the Protective Effect of Baicalein on Carbon Tetrachloride-Induced Acute Liver Injury
by: Chongshan Dai, et al.
Published: (2021) -
Polymyxins: To Combine or Not to Combine?
by: Federico Perez, et al.
Published: (2019)